Asperger syndrome
Information
- Disease name
- Asperger syndrome
- Disease ID
- DOID:0050432
- Description
- "An autism spectrum disorder that is characterized by significant difficulties in social interaction, along with restricted and repetitive patterns of behavior and interests. It differs from other autism spectrum disorders by its relative preservation of linguistic and cognitive development." [url:http\://en.wikipedia.org/wiki/Asperger_syndrome, url:http\://www.neurodevnet.ca]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| SCN1A | 2 | 165,985,813 | 166,128,020 | 4 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03170453 | Active, not recruiting | N/A | Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder | June 1, 2015 | December 31, 2024 |
| NCT00280670 | Completed | Phase 2 | CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS | January 2005 | August 2009 |
| NCT00453180 | Completed | Phase 2 | A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders | March 2007 | November 2009 |
| NCT00464477 | Completed | Advanced Grandparental Age as a Risk Factor for Autism | June 2007 | October 2007 | |
| NCT00619190 | Completed | Phase 2 | Study of Aripiprazole to Treat Children and Adolescents With Autism | January 2006 | June 2012 |
| NCT00261508 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) | August 1999 | December 2001 |
| NCT01337700 | Completed | Phase 4 | Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism | February 2011 | July 2014 |
| NCT01592747 | Completed | Phase 2 | Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine | September 2012 | October 2013 |
| NCT01655173 | Completed | N/A | Cognitive Behavioural Therapy (CBT) and Recreational Activity for Autism Spectrum Disorders (ASD) | August 2005 | September 2011 |
| NCT01731119 | Completed | Phase 2 | Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents | December 2012 | August 2014 |
| NCT01921244 | Completed | N/A | Shared Decision Making to Improve Care and Outcomes for Children With Autism | August 2013 | July 2015 |
| NCT02250339 | Completed | A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders | December 2013 | June 30, 2018 | |
| NCT02800681 | Completed | Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample | June 2016 | December 2018 | |
| NCT03560453 | Completed | N/A | Facilitating Employment for Youth With Autism | August 1, 2013 | March 15, 2018 |
| NCT04788537 | Completed | N/A | Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders | February 16, 2021 | June 22, 2023 |
| NCT00725556 | Completed | Phase 1/Phase 2 | The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist | March 2006 | December 2007 |
| NCT00848874 | Completed | N/A | Portable Visual Guidance System Phase II | September 2008 | March 2010 |
| NCT01187784 | Completed | Phase 1 | Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety | May 2009 | August 2010 |
| NCT05509231 | Not yet recruiting | N/A | Effects of a Multimodal Exercise Program for Children With ASD | January 12, 2024 | January 31, 2024 |
| NCT05958680 | Recruiting | N/A | ASDactive: An Integrated Theory-based Intervention to Promote Habitual Physical Activity | October 1, 2023 | October 1, 2024 |
| NCT06227780 | Recruiting | N/A | Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders | May 24, 2023 | May 24, 2028 |
| NCT06187090 | Recruiting | N/A | The Supplementation Therapy in Autism and Response to Treatment Study | September 1, 2023 | November 2026 |
| NCT04654260 | Recruiting | N/A | Behavior Therapy for Irritability in Autism | December 10, 2020 | August 30, 2025 |
| NCT04532424 | Suspended | N/A | Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD | January 4, 2021 | March 1, 2025 |
| NCT03672266 | Unknown status | Studies of Brain and Body Interaction | August 1, 2018 | July 1, 2019 | |
| NCT00505830 | Unknown status | Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ | July 2007 | July 2009 | |
| NCT00693953 | Withdrawn | Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism | January 2010 | December 2012 |
- Disase is a (Disease Ontology)
- DOID:0060041
- Cross Reference ID (Disease Ontology)
- GARD:5855
- Cross Reference ID (Disease Ontology)
- ICD10CM:F84.5
- Cross Reference ID (Disease Ontology)
- MESH:D020817
- Cross Reference ID (Disease Ontology)
- MIM:608631
- Cross Reference ID (Disease Ontology)
- MIM:608638
- Cross Reference ID (Disease Ontology)
- MIM:608781
- Cross Reference ID (Disease Ontology)
- MIM:609954
- Cross Reference ID (Disease Ontology)
- MIM:PS608638
- Cross Reference ID (Disease Ontology)
- NCI:C97159
- Cross Reference ID (Disease Ontology)
- ORDO:1162
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154879004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0236792
- ICD10 preferred id (Insert disease from ICD10)
- D0004721
- ICD10 class code (Insert disease from ICD10)
- F84.5